RxKinetix Inc.
This article was originally published in Start Up
Executive Summary
RxKinetix is developing two polymer-based sustained release delivery systems. {Micronix} permits water soluble drugs, including proteins, peptides and oligonucleotides, to be blended with polymers in microparticles 1-5 microns in diameter. {ProGelz} achieves site-specific sustained release of macromolecules.
You may also be interested in...
Drug Delivery Start-ups
Knowing that the competition's tougher, the new crop of drug delivery companies grows increasingly specialized.
Wound Solutions Ltd.
Wound Solutions Ltd. looks to the paradigm of patient self-care in diabetes to address the gaps in chronic wound care, where the feedback provided by blood glucose monitoring encourages changes in behavior. A small device that is placed under a compression bandage helps patients with venous leg ulcers comply with the steps they should be taking to support wound healing, in the process, collecting data that helps clinicians make informed therapy decisions.
Patient-Centric Devices Promise Cost-Efficient Advanced Wound Care
The treatment of chronic wounds is challenging, not only because of the underlying biology, but also because of more practical considerations: fragmentation in the care settings, the logistics of delivering products to patients, and the costs of chronic care. Next generation advanced wound care companies are engineering solutions to these problems.